000			01756nam a22003497a 4500
001			43484
003			BD-DhAAL
008			241002t2024 enka r 000 0 eng d
020			_a9780113231041
040			_aBD-DhAAL _cBD-DhAAL
082	0	0	_a615.11 _223
245	0	0	_aBritish pharmacopoeia _f2025. _nVolume I.
246			_aBritish pharmacopoeia 2025
260			_aLondon : _bThe Stationery Office, _c2025.
300			_aI-xxxii, I-1417 pages : _billustrations ; _c31 cm.
362			_aVol. 1
500			_aEffective date 1st January 2025.
500			_aIncorporating the requirements of the 11th edition of the European Pharmacopoeia as amended by Supplements 11.1 to 11.5.
505	0		_av. 1. Foreword -- Notices -- Preface -- British pharmacopoeia commission -- Expert advisory groups, panels of experts and working parties -- Code of practice -- Membership -- Staff -- Introduction -- General notices -- Monographs [Medicinal and Pharmaceutical Substances (A-I)].
526	8		_aPHR
650		0	_aPharmacopoeias. _944450
650		0	_aPharmacopoeias _zGreat Britain.
650		0	_aDrugs _xStandards _zGreat Britain. _944451
650		0	_aPharmacy. _944452
710			_aGreat Britain. _bDepartment of Health & Social Care. _959992
710			_aNorthern Ireland. _bDepartment of Health (HI). _959995
710			_aGreat Britain. _bMedicines and Healthcare products Regulatory Agency. _959993
710			_aBritish Pharmacopoeia Commission. _959994
852	1		_aAyesha Abed Library _cReference Section
942			_2ddc _cBK
999			_c46912 _d46912